Tricuspid regurgitation

What Is Tricuspid Regurgitation?

Tricuspid regurgitation is a condition in which the tricuspid valve, located between the right atrium and right ventricle, fails to close completely, allowing blood to flow backward into the right atrium each time the right ventricle contracts. Over time, this backward flow forces the right side of the heart to work harder and can lead to progressive enlargement of its chambers.¹

For many years, tricuspid regurgitation received far less clinical attention than valve disease affecting the left side of the heart, earning it an informal reputation as the forgotten valve. That has changed considerably in recent years, as research has increasingly linked significant tricuspid regurgitation to worse survival and meaningfully reduced quality of life, prompting renewed interest in dedicated diagnosis and treatment.²

Tricuspid regurgitation is remarkably common, affecting more than four percent of people over the age of seventy five when assessed with echocardiography, and it is diagnosed more frequently in women than in men, a difference researchers believe may be related to longer female life expectancy and a higher prevalence of certain heart failure patterns in women.¹

Tricuspid regurgitation is one of the most common heart valve diseases and is associated with a poor prognosis, since significant regurgitation increases mortality risk compared with mild or no regurgitation at all.
National Center for Biotechnology Information

Symptoms

Because the right ventricle is relatively compliant and can accommodate volume overload for a long time, symptoms of tricuspid regurgitation often develop gradually and may not become noticeable until the condition has progressed considerably.¹

Common symptoms include fatigue, reduced exercise tolerance, and shortness of breath with exertion. As regurgitation becomes more severe, patients frequently develop signs of fluid buildup in the body, including swelling in the legs and abdomen, distended neck veins, and, in more advanced cases, fluid accumulation within the abdominal cavity known as ascites.¹

In acute or particularly severe cases, tricuspid regurgitation can present much more dramatically, with symptoms ranging from significant breathlessness at rest to signs of cardiogenic shock, though this presentation is considerably less common than the slow, progressive pattern seen in most patients.¹

Causes

The overwhelming majority of significant tricuspid regurgitation, roughly eighty five to ninety percent of severe cases, is classified as functional or secondary regurgitation, meaning the valve leaflets themselves are structurally normal but fail to close properly because the surrounding right ventricle and valve annulus have become enlarged.³

This enlargement most often results from left sided heart disease, since elevated pressure within the left side of the heart eventually backs up into the lungs and right heart chambers, a cascade that frequently begins with conditions such as mitral valve disease, longstanding atrial fibrillation, or heart failure with preserved ejection fraction.³

Primary tricuspid regurgitation, in which the valve leaflets themselves are structurally abnormal, is considerably less common and can result from infective endocarditis, rheumatic disease, carcinoid syndrome, trauma, or damage caused by a pacemaker or defibrillator lead passing directly through the valve.¹

Risk Factors

Age is among the strongest risk factors for tricuspid regurgitation, with prevalence rising substantially in older adults as the cumulative effects of other cardiovascular conditions accumulate over time.¹

Atrial fibrillation is closely linked to functional tricuspid regurgitation, since the irregular rhythm frequently leads to progressive enlargement of the right atrium, which stretches the tricuspid annulus and prevents the leaflets from meeting properly during contraction.³

Pulmonary hypertension, whatever its underlying cause, raises pressure within the right ventricle and contributes significantly to right heart enlargement and subsequent valve regurgitation. A pacemaker or defibrillator lead that crosses the tricuspid valve, prior heart surgery, and known left sided valve disease also meaningfully raise the likelihood of developing significant tricuspid regurgitation.¹

Complications

Progressive tricuspid regurgitation places ongoing strain on the right ventricle, and over time this can lead to right sided heart failure, a condition marked by persistent fluid retention throughout the body and reduced overall cardiac output.¹

Because blood returning to the heart from the body must pass through the right side before reaching the lungs, chronic tricuspid regurgitation frequently leads to venous congestion affecting the liver and kidneys, sometimes resulting in impaired organ function that further complicates management of the underlying valve disease.²

Studies following patients over extended periods have consistently found that severe tricuspid regurgitation is associated with meaningfully worse long term survival compared with mild or absent regurgitation, independent of other underlying cardiac conditions a patient may have.⁴

Treatment

Diuretic medication is commonly used to manage fluid retention associated with tricuspid regurgitation, providing symptomatic relief even though it does not address the underlying valve dysfunction itself.¹

Surgical repair or replacement has traditionally been the standard definitive treatment, though isolated tricuspid surgery, performed without an accompanying left sided procedure, carries a notably higher in hospital mortality rate, generally cited between eight and ten percent, along with a longer hospital stay compared with many other valve procedures.⁵

Transcatheter edge to edge repair, using a small clip delivered through a catheter to bring the tricuspid leaflets closer together, has emerged as a promising, less invasive option for patients considered poor surgical candidates. Large clinical trials, including the TRILUMINATE Pivotal study, have demonstrated meaningful reductions in regurgitation severity along with improved functional status and quality of life following this procedure.⁶

Prevention

Because the majority of tricuspid regurgitation cases develop secondary to other cardiac conditions, preventing or effectively managing those underlying conditions offers the most meaningful path to reducing risk. Prompt treatment of left sided valve disease, effective rhythm control for atrial fibrillation, and appropriate management of pulmonary hypertension all help limit the right heart enlargement that drives most cases of functional regurgitation.³

For patients requiring a pacemaker or defibrillator, careful attention to lead placement and monitoring for valve related complications over time can help reduce the risk of lead associated tricuspid regurgitation developing later.¹

Because significant tricuspid regurgitation is closely tied to survival, regular echocardiographic monitoring in patients with known risk factors, such as atrial fibrillation or left sided heart disease, allows physicians to identify worsening regurgitation early and consider intervention before right heart function declines further.⁴

Why Visual Communication Matters for Tricuspid Regurgitation

The tricuspid valve’s central role in right heart function is often poorly understood by patients, and explaining how leaking blood on the right side of the heart leads to swelling, liver congestion, and reduced quality of life requires visuals that make an otherwise invisible mechanical problem tangible and understandable.¹

Structural heart device manufacturers, cardiology practices, and patient education programs rely on precise illustration and animation to explain the mechanisms behind tricuspid regurgitation and the growing range of treatment options available.

• Illustrating normal tricuspid valve function compared with regurgitant blood flow
• Animating how right ventricular enlargement leads to functional tricuspid regurgitation
• Explaining transcatheter edge to edge repair and other emerging device therapies
• Visualizing how tricuspid regurgitation contributes to fluid retention and organ congestion
• Supporting patient education on symptom recognition and treatment options
• Creating training materials for structural heart teams on patient selection and procedural planning

How Biotic Artlab Supports Tricuspid Regurgitation Communication

We partner with structural heart device manufacturers, cardiology practices, and healthcare organizations to create precise, engaging visuals that make tricuspid valve disease and its treatment understandable for patients, clinicians, and industry audiences.

• Custom 3D animations of tricuspid valve anatomy and regurgitant blood flow
• Detailed illustrations of transcatheter and surgical treatment approaches
• Patient facing educational materials explaining diagnosis and treatment pathways
• Clinical training content for structural heart and cardiac catheterization teams
• Regulatory and investor facing visuals explaining device mechanism of action
• Conference presentations and marketing materials for structural heart audiences

Frequently Asked Questions

Why was tricuspid regurgitation historically undertreated?

The tricuspid valve received comparatively little research and clinical attention for decades, and symptoms can be subtle and easy to attribute to other causes. Growing evidence linking significant regurgitation to worse survival has driven renewed interest in dedicated treatment options.²

What causes most cases of tricuspid regurgitation?

The large majority of cases are functional, meaning the valve itself is structurally normal but fails to close properly because the surrounding right ventricle and valve annulus have enlarged, most often as a consequence of left sided heart disease.³

Is surgery the only treatment option for tricuspid regurgitation?

No. While surgery remains a standard treatment, it carries meaningful risk, particularly when performed as an isolated procedure. Transcatheter edge to edge repair now offers a less invasive alternative for patients considered poor surgical candidates.⁶

Why does tricuspid regurgitation cause leg and abdominal swelling?

Blood leaking backward through the tricuspid valve raises pressure in the veins throughout the body, since this is the pathway blood must travel through before reaching the lungs. This elevated pressure leads to fluid retention in the legs, abdomen, and sometimes the liver.¹

Can tricuspid regurgitation affect the liver or kidneys?

Yes. Chronic venous congestion caused by tricuspid regurgitation can impair blood flow through the liver and kidneys over time, sometimes contributing to organ dysfunction that complicates overall management of the condition.²

How effective is transcatheter edge to edge repair for tricuspid regurgitation?

Clinical trials have shown meaningful and sustained reductions in regurgitation severity along with improved functional status and quality of life. Benefits for hard outcomes such as mortality remain an active area of ongoing research, particularly in patients with preserved right ventricular function.⁶

Have a Project in Mind? Contact Us.

If you are developing training materials, patient education content, or marketing visuals related to tricuspid regurgitation or structural heart disease, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information, StatPearls. Tricuspid Regurgitation.
2. National Center for Biotechnology Information. Tricuspid Regurgitation, A Comprehensive Review of Clinical, Imaging and Therapy.
3. National Center for Biotechnology Information. Secondary Tricuspid Regurgitation, Pathophysiology, Incidence and Prognosis.
4. American Heart Association, Journal of the American Heart Association. Long Term Clinical Outcomes in Patients With Severe Tricuspid Regurgitation.
5. National Center for Biotechnology Information. Diagnostic Management and Surgical Treatment of Isolated Tricuspid Regurgitation.
6. National Center for Biotechnology Information. Tricuspid Transcatheter Edge to Edge Repair at a Crossroads, Prognosis Shaping Intervention or High Tech Palliation.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.